In vivo imaging of transgenic Leishmania parasites in a live host

Journal of Visualized Experiments

Volumn , Issue 41, 2010, Pages

  Thalhofer, Colin J ^a   Graff, Joel W ^a   Love Homan, Laurie ^b   Hickerson, Suzanne M ^c   Craft, Noah ^d   Beverley, Stephen M ^c   Wilson, Mary E ^b,e  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bioluminescence; Cutaneous leishmaniasis; In vivo imaging; Issue 41; IVIS; Leishmania; Luciferase; Microbiology; Parasite; Transgenic; Visceral leishmaniasis

Indexed keywords

EID: 80055102308     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/1980     Document Type: Article

References (22)

1. Capul, A. A., Barron, T., Dobson, D. E., Turco, S. J. & Beverley, S. M. Two functionally divergent UDP-Gal nucleotide sugar transporters participate in phosphoglycan synthesis in Leishmania major. J Biol Chem 282, 14006-14017, doi:M610869200 [pii] 10.1074/jbc.M610869200 (2007).
2. LeBowitz, J. H., Coburn, C. M., McMahon-Pratt, D. & Beverley, S. M. Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes. Proc Natl Acad Sci U S A 87, 9736-9740 (1990).
3. Mureev, S., Kushnir, S., Kolesnikov, A. A., Breitling, R. & Alexandrov, K. Construction and analysis of Leishmania tarentolaetransgenic strains free of selection markers. Mol Biochem Parasitol 155, 71-83 (2007).
4. Chakkalath, H. R. et al. Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major. Infect Immun 68, 809-814 (2000).
5. Sacks, D. L. & Perkins, P. V. Identification of an infective stage of Leishmania promastigotes. Science 223, 1417-1419 (1984).
6. da Silva, R. & Sacks, D. L. Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation. Infect Immun 55, 2802-2806 (1987).
7. Spath, G. F. & Beverley, S. M. A lipophosphoglycan-independent method for isolation of infective Leishmania metacyclic promastigotes by density gradient centrifugation. Exp Parasitol 99, 97-103, doi:10.1006/expr.2001.4656 S0014-4894(01)94656-9 [pii] (2001).
8. Scott, P., Caspar, P. & Sher, A. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes. J Immunol 144, 1075-1079 (1990).
9. Belkaid, Y. et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 194, 1497-1506 (2001).
10. Wilson, M. E. et al. Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication ofLeishmania chagasi. J Immunol 156, 2231-2239 (1996).
11. McElrath, M. J., Murray, H. W. & Cohn, Z. A. The dynamics of granuloma formation in experimental visceral leishmaniasis. J Exp Med 167, 1927-1937 (1988).
12. Ato, M. et al. Loss of dendritic cell migration and impaired resistance to Leishmania donovani infection in mice deficient in CCL19 and CCL21. J Immunol 176, 5486-5493, doi:176/9/5486 [pii] (2006).
13. Ahmed, S. et al. Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect Immun 71, 401-410 (2003).
14. Kamala, T. Hock immunization: a humane alternative to mouse footpad injections. J Immunol Methods 328, 204-214, doi:S0022-1759(07)00248-7 [pii] 10.1016/j.jim.2007.08.004 (2007).
15. Hickerson, S. M., J. Prior, D. Piwnica-Worms, and S.M. Beverley manuscript in preparation.
16. Lang, T., Goyard, S., Lebastard, M. & Milon, G. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice. Cell Microbiol 7, 383-392, doi:CMI468 [pii] 10.1111/j.1462-5822.2004.00468.x (2005).
17. Brittingham, A., Miller, M. A., Donelson, J. E. & Wilson, M. E. Regulation of GP63 mRNA stability in promastigotes of virulent and attenuated Leishmania chagasi. Mol Biochem Parasitol 112, 51-59, doi:S0166-6851(00)00346-7 [pii] (2001).
18. Roy, G. et al. Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models. Mol Biochem Parasitol 110, 195-206, doi:S0166-6851(00)00270-X [pii] (2000).
19. Contag, C. H. et al. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol 18, 593-603 (1995).
20. Hardy, J., Margolis, J. J. & Contag, C. H. Induced Biliary Excretion of Listeria monocytogenes. Infect. Immun. 74, 1819-1827, doi:10.1128/iai.74.3.1819-1827.2006 (2006).
21. Lecoeur, H. et al. Optimization of Topical Therapy for Leishmania major Localized Cutaneous Leishmaniasis Using a Reliable C57BL/6 Model. PLoS Negl Trop Dis 1, e34, doi:10.1371/journal.pntd.0000034 (2007).
22. Lang, T., Lecoeur, H. & Prina, E. Imaging Leishmania development in their host cells. Trends Parasitol 25, 464-473, doi:S1471-4922(09)00161-5 [pii] 10.1016/j.pt.2009.07.006 (2009).